YSOPIA Bioscience

[On Demand]
Search General Info
Search Education
Search Partnering Companies
YSOPIA Bioscience is a French clinical stage biotech company specializing in the research and development of therapeutic innovations harnessing the potential of the gut microbiome.

YSOPIA develops groundbreaking biotherapies using single-strain keystone bacteria. Its most advanced development program is currently in Phase 1 clinical trial under FDA regulation and targets obesity and associated metabolic diseases. YSOPIA’s portfolio also includes three other innovative programs addressing chronic indications with substantial unmet medical needs (inflammatory diseases, mood disorders and oncology).
Supported by leading venture capital investors and family offices, YSOPIA Bioscience has established collaborative projects worldwide with renowned scientific institutions and academic experts to maintain the highest standards in the development of its innovative biotherapeutics.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
France
Year Founded:
2010
Main Therapeutic Focus:
Lead Product in Development:
Xla1 biotherapy
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
YSOPIA Bioscience